New injection aims to tame severe eczema itch and rash
NCT ID NCT07321951
Summary
This study is testing an investigational injection called SHR-1819 to see if it can safely reduce the skin rash and severe itching caused by moderate-to-severe atopic dermatitis (eczema). About 200 adult participants will be randomly assigned to receive either the study drug or a placebo to compare results. The main goal is to see if the treatment can significantly clear skin and reduce itchiness for patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MODERATE TO SEVERE ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Dermatology Hospital of Southern Medical University
RECRUITINGGuangzhou, Guangdong, 510091, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
-
Hangzhou Third People's Hospital
RECRUITINGHangzhou, Zhejiang, 310009, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.